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Abstract
Falls in older people are a major public health concern in terms of morbidity, mortality and cost.
Previous studies suggest that multifactorial interventions can reduce falls, and many geriatric day
hospitals are now offering falls intervention programmes. However, no studies have investigated
whether these programmes, based in the day hospital are effective, nor whether they can be
successfully applied to high-risk older people screened in primary care.
The hypothesis is that a multidisciplinary falls assessment and intervention at Day hospitals can
reduce the incidence of falls in older people identified within primary care as being at high risk of
falling. This will be tested by a pragmatic parallel-group randomised controlled trial in which the
participants, identified as at high risk of falling, will be randomised into either the intervention Day
hospital arm or to a control (current practice) arm. Those participants preferring not to enter the
full randomised study will be offered the opportunity to complete brief diaries only at monthly
intervals. This data will be used to validate the screening questionnaire. Three day hospitals (2
Nottingham, 1 Derby) will provide the interventions, and the University of Nottingham's
Departments of Primary Care, the Division of Rehabilitation and Ageing Unit, and the Trent
Institute for Health Service Research will provide the methodological and statistical expertise. Four
hundred subjects will be randomised into the two arms. The primary outcome measure will be the
rate of falls over one year. Secondary outcome measures will include the proportion of people
experiencing at least one fall, the proportion of people experiencing recurrent falls (>1), injuries,
fear of falling, quality of life, institutionalisation rates, and use of health services. Cost-effectiveness
analyses will be performed to inform health commissioners about resource allocation issues. The
importance of this trial is that the results may be applicable to any UK day hospital setting.
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Sites: General practices across Nottinghamshire and Derbyshire.
Day hospitals:
Derbyshire Royal Infirmary (Southern Derbyshire Acute Hospitals NHS Trust)
Sherwood Day Service (Nottingham City Hospital Trust)
Leengate Day Hospital (Queen's Medical Centre Nottingham University Hospital NHS Trust)
Background
Falls are a common and serious problem facing elderly
people and are associated with considerable mortality and
morbidity [1]. Forty to sixty percent of falls cause injuries
with an estimated 5% of incident falls resulting in frac-
tures[2,3]. Falls result in institutionalisation[4], hospitali-
sation[5] and injury-related death[6]. Over the age of 65
years a third of the population fall at least once a year [7]
rising to over a half by 85 years [2]. Previous studies have
identified a number of potentially modifiable fall risk fac-
tors[1]. Intervention studies in the USA and New Zealand
have shown that a combined multidisciplinary assess-
ment and treatment programme and an individualised
home based targeted exercise programme respectively can
reduce falls by 30%-46% [8-10]. The UK PROFET study
showed that in patients presenting to an Accident and
Emergency department with a fall, the number of subse-
quent falls were reduced by half in those who had received
the intervention, which constituted a thorough medical
assessment and an occupational therapy home visit[11].
In 1999 there were 647,721 A&E attendances and 204,424
admissions to hospitals in the UK as a result of injuries
sustained in unintentional falls by the over 60's. It was cal-
culated that these falls cost the UK Government a total of
£981 million, £581 million of which was met by the NHS.
The main cost components were inpatient admissions
(making up 49.4% of total costs) and long term care costs
(accounting for 41%). The costs incurred as the result of a
fall increased with age[12].
We do not know whether interventions provided to high
risk older people identified in primary care are effective,
nor whether falls programmes now offered by day hospi-
tals are sufficiently well constituted and intensive to
deliver similar benefits to those studies outlined above.
Nor do we know if day hospital settings will be acceptable
to the 'screened well'. Addressing 'fear of falling' and con-
sequent social isolation or restriction are key features of
an effective falls prevention programme. The proposed
multi-centre randomised controlled trial will assess
whether falls can be successfully and cost-effectively
reduced using day hospital facilities.
In addition to assessing the effectiveness of the Day hos-
pital as an intervention to reduce falls it is important to
evaluate the intervention in terms of its cost-effectiveness.
In a resource constrained health care system it is impor-
tant to ensure that limited resources are spent in such a
way as to maximise outcomes. Within the context of this
proposed study the economic objective is to establish
whether it is efficient to allocate resources to the Day hos-
pital, in comparison to standard care, as an intervention
to reduce falls amongst elderly people. To address the effi-
ciency of putting resources to Day hospitals a cost-effec-
tiveness analysis and cost-utility analysis will be
performed.
Objectives
Main research hypothesis and question
The main hypothesis to be tested is that a multidiscipli-
nary falls assessment and intervention occurring at a Ger-
iatric Day hospital can decrease the rate of falls over the
course of one year, in older people identified in primary
care as being at high risk of falling.
Secondary research questions
1. Can the above intervention reduce the proportion of
people with single or recurrent falls (>1)?
2. Can the above intervention reduce fall-related injuries
(including fractures)?
3. Can the above intervention reduce disability and
improve quality of life?
4. Can the above intervention reduce institutionalisation
and the need for the use of health services?
5. Is the intervention cost-effective and might it lead to
overall cost-savings?
6. Can a screening questionnaire used in primary care reli-
ably distinguish between low and high risk of falling?
7. Is there any difference in deaths between the two
groups?Trials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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Subject definition
The study population will comprise men and women
aged 70 and over identified at being at high risk of falling
by a postal screening questionnaire, registered with the
participating general practices in Nottinghamshire and
Derbyshire.
Exclusion criteria
Patients already attending one of the day hospitals
Patients under follow-up with an existing primary care
based falls prevention scheme or day hospital falls service
Residents in nursing or residential homes
Patients with terminal illnesses
Those unwilling or unable to travel to the day hospital
(using transport as provided)
Study design and treatment definition
Study design
The proposed study is a pragmatic parallel group ran-
domised controlled trial where the participants will be
randomised into either the intervention day hospital arm
or to a control (current practice) arm. After outcome
measurement has taken place those in the control arm
will be offered the day hospital intervention.
Intervention & control groups
The two arms of the study are as follows:
• Intervention arm: screening questionnaire, information
leaflet, leaflet on falls prevention and invitation to attend
the day hospital for assessment and any subsequent inter-
vention
• Control arm: screening questionnaire, information leaf-
let, leaflet on falls prevention and usual care from primary
care service until outcome data collected, then offer of day
hospital intervention.
Procedures and observations
In most cases, subjects will be contacted by post and tele-
phone at each stage of the study; however, it is likely that
some individuals will be unable or unwilling to use these
methods in which case they will be offered a home visit.
Baseline measurements
Participating general practices will be asked to identify all
patients aged 70 and over in their practice. Practices will
be asked to exclude all those living in a nursing or residen-
tial home and those with terminal illness. The remaining
subjects will be sent an invitation to participate by their
general practice.
The invitation will include the patient information leaflet
as well as a screening questionnaire which the subjects
will be asked to return to the project officer. This screening
questionnaire is based on published guidelines[1] and
will be adapted for the local population in a pilot study.
Those subjects not participating in the randomised study
will be offered the opportunity to complete the monthly
diaries only; data from these replies will be used to
explore the predictive strengths of the screening question-
naire. The screening questionnaire will enable the identi-
fication of subjects deemed to be at high risk of falling and
will include questions on previous falls history, mobility,
use of walking aids and the number of medications. In
addition to returning the questionnaire, subjects will be
asked if they would be interested in participating in the
study and if so to provide contact details, including phone
number. The screening questionnaire will also ask about
other exclusion criteria such as attendance at the day hos-
pital. The replies will be analysed by the project officer
and suitable participants for the study identified. Poten-
tial participants will be asked if they have had contact with
either the day hospital or the primary care falls prevention
service in the preceding year; in case of any doubt, verbal
consent will be obtained to check their possible contact
with these services with the day hospital or the primary
care team.
A written invitation will be sent offering a home visit from
the study nurse where no telephone contact is possible.
Those eligible subjects thought to be at high risk of future
falls (approximately 1000) will then be sent a pack con-
taining further information on the study, a falls preven-
tion booklet ('Avoiding slips, trips and broken hips',
Department of Health) and a consent pack.
The subjects will then be contacted by phone with the aim
of:
• Clarifying any issues about the study
• Confirm responses to the screening questionnaire
• Invitation to take part
• Obtaining verbal consent (based on a standardised
schema) and requesting signing and return of consent
form in prepaid envelope
On receipt of the signed consent form, the project officer
will then contact the randomisation centre. Subjects will
be informed of the next steps by phone, with confirma-
tion by post within 48 hours. This second letter will
include information on which arm they have been ran-Trials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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domised, the diaries for recording falls and if appropriate,
an appointment for the day hospital.
For those willing to take part but who do not want to be
part of the main RCT, there will be the option of returning
a brief falls diary and the end of study questionnaire only.
Outcome measurements
Definition of primary and secondary outcomes
Primary outcome: rate of falling over the 12 month fol-
low-up period.
Falls will be recorded by giving each participant a diary
and reply paid envelopes. The definition of a fall given to
subjects in this study will be 'inadvertently coming to rest
on the ground or other lower level with or without loss of
consciousness and other than as a consequence of sudden
onset of paralysis, epileptic seizure, excess alcohol intake,
or overwhelming external force' (PROFET[11]).
Participants will be asked to record falls in the diary, along
with the outcome (saw GP, phoned ambulance, sent to
hospital, injuries). The diaries will be mailed back to the
research team at the end of every month. Participants will
be contacted via telephone by the "blinded" assessor at
the end of each month to encourage return of the diary.
Falls will be monitored until, withdrawal from study,
death or end of 12 month follow up, which ever event
occurs first.
Secondary outcomes:
1. Proportion of people with single or recurrent falls
(>1)... defined as above
2. Fall-related injuries: fracture, serious sprain requiring
immobilisation in plaster, joint dislocations, head injury
requiring hospitalisation, and lacerations requiring sutur-
ing
3. Disability: Nottingham Extended Activities of Daily Liv-
ing Scale; Barthel index of daily living; Quality of life: Falls
Efficacy Scale and EuroQoL-5
4. Institutionalisation and use of health services: residency
and diary information
5. Cost analysis
6. Screening tool... defined by sensitivity/specificity as
well as positive and negative predictive values
7. Deaths will be checked against PCT records and meas-
ured as proportions
Ascertainment of outcomes
The principal method will be self-reporting using the
diary. This will contain a section on falls and the out-
comes (carried on as usual, called for help, waited for
someone to help, called GP, called ambulance, taken to
hospital, nature of any injury). Additionally, there will be
a section recording health service utilisation, covering pri-
mary care contacts and hospital admissions.
The self-reported data will be cross referenced where pos-
sible through access to GP records and hospital informa-
tion systems. For hospital admissions, access to the case
notes will be requested and the notes reviewed. This level
of information will allow a more accurate ascertainment
of events as well as the costs associated. Information on
falls-related drug treatment (such as bone protection ther-
apy) will be obtained from the GP records. These data will
be collected by the project manager and project officer on
standardised forms. The data collection will be subject to
internal audit to ensure accurate and consistent data
recording and avoid intraobserver and interobserver bias.
Institutionalisation data will be available from practice
registers. Those who change practice as a result of chang-
ing address will be traced through the primary care trusts.
Disability and quality of life will be self reported by study
participants. They will be asked to complete the Notting-
ham extended activities of daily living scale (NEADL)[24],
Barthel index of Daily Living, EuroQol[25] and the falls
efficacy scale[26]. These will be posted at the end of one
year, along with reply paid envelopes. Non-responders
will be sent a written reminder and if necessary a follow-
up phone call ('hot pursuit').
EuoQol is included to facilitate cost-effectiveness and
cost-utility calculations, but the Falls Efficacy Scale (FES)
is a more sensitive measure of quality of life in this popu-
lation, hence its inclusion[27]. The FES has been validated
in the UK as both a face to face and self completed ques-
tionnaire[27]. The intraclass correlation coefficient is
0.58, suggesting fair agreement when used as a postal
questionnaire. Both the Barthel index and the NEADL are
well validated measures of functional ability and can be
used as a postal questionnaire[24].
Patients not recruited into the study
Data will be available from the screening questionnaire
for those patients who prefer not to participate in the ran-
domised trial or who are excluded as per the study proto-
col, but who agree to complete the monthly diaries and
end of study booklet. Using this data it will be possible to
check the representative nature of the study population
and the discriminatory power of the screening question-
naire. Those subjects who prefer not to take part in theTrials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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study at either level will not be contacted any further. They
will have access to usual care through their GPs/primary
care teams.
Randomisation
After giving informed consent patients will be randomly
allocated (1:1 ratio) to either the intervention group or to
the control group. Randomisation will be made by tele-
phone to the TRDSU who will be blind to the identity of
the patient, and will use a computer program (Stata) to
carry out stratified block randomisation based on study
centre (Nottingham, Derby).
Treatment
Intervention arm
The intervention arm will be invited to attend the day hos-
pital for an assessment and any subsequent intervention,
including:
Medical assessment and treatment performed by a clinician
History (including medications) [standard format]; a full
physical examination including visual acuity and orthos-
tatic blood pressure measurement; laboratory tests where
indicated; 12 lead ECG and where appropriate a neurov-
ascular assessment (carotid sinus massage and tilt tests).
Treatments will vary according to the medical diagnoses
made and will include medication review, appropriate
referral to an optician or ophthalmologist for visual
impairment and referral to other specialists where neces-
sary.
Physiotherapy assessment and individualised therapy programme 
conducted by a physiotherapist
Assessment for gait, balance, mobility and muscle
strength (using the Tinetti[15] method and measurement
of ankle dorsiflexion strength[16]). Interventions will
include gait re-education and functional training pro-
gramme using the principles of Koch[17], and muscle
strengthening exercise programme based on a modified
Dunedin protocol[10], and where indicated the provision
of an appropriate walking aid. The feet and footwear will
be assessed for abnormalities that could impair gait and
appropriate referrals will be made to a chiropodist or an
orthotist. The number and timings of follow up visits at
the day hospital for further assessment and therapy and
telephone calls to check compliance with the programme
will depend on the individualised needs of the partici-
pants.
Occupational therapy assessment and modifications, performed by 
an occupational therapist
Interview with the participant using a standardised check-
list to investigate home hazards[18]. Where necessary, a
home visit will then also be performed. Participant's func-
tioning will be assessed using a standard activities of daily
living measure[19]. Modification of identified environ-
mental hazards will be suggested according to published
criteria[18].
Control arm
In addition to the falls prevention leaflet, the control
group will receive all routine care provided by their pri-
mary care service. This may or may not include referral to
secondary care, depending on the GP's judgement. At
present, there are primary care falls prevention services
being developed, but in an inconsistent manner. Partici-
pation in the control arm may include referral to such
services as part of normal practice, but these referrals will
not constitute part of the trial protocol. Patients in the
intervention arm will be asked not to participate in the
primary care falls prevention services for the duration of
the trial. Assuming the trial does not show a detrimental
effect from the day hospital intervention, the control
group will be offered day hospital attendance at the end of
the trial.
Contamination
Pilot data from the Nottingham Community Osteoporo-
sis (NOCOS) study[20] suggest that very few older
patients identified as fallers are referred to secondary care
or other agencies for a falls assessment (personal commu-
nication with Trial Co-ordinator). Although contamina-
tion between groups is a potential limitation, our
previous experience suggests this is unlikely to be an
important issue. We will specifically check to see if any of
the control group have attended secondary care services
for a falls evaluation. Currently all referrals to the primary
care falls prevention services are centralised within each
primary care trust; through checking with these centres,
we will be able to ascertain who in the control group
received a primary care based intervention. We will also
use this point of contact to ensure that those in the day
hospital arm of the trial are not also receiving a commu-
nity intervention or follow-up.
Withdrawal
Participants wishing to withdraw from the study will be
free to do so at any stage, without any detriment to their
usual care.
Concurrent treatment
There are no other falls prevention studies running in this
area at present that might be relevant. Community falls
prevention programmes are being developed, but we will
liaise with these groups to ensure that the day hospital
group are not put into these services. The control group
will be able to access these services in the usual fashion.Trials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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Data analysis
Power and sample size
With an expected rate of falls of 2/year per person[11],
and an over dispersion parameter of 1.5 a clinically
important risk reduction of 24% to 1.5 falls/year can be
detected with 80% power and 5% significance (two-
sided) in a trial of 160 participants in each arm giving a
trial size of 320. This assumes a Poisson distribution with
over dispersion. If the fall rate was 1/year per person[10]
a risk reduction of 33% could be detected with this sample
size (not a high risk population). To allow for an attrition
rate of 20% (see below) we will recruit a total of 400 par-
ticipants. To achieve this, 3125 subjects will need to be
screened, of whom 40% may be at high risk of falls. Of
these 1250, 20% are likely to be ineligible leaving 1000
potential participants of whom it is thought that 40% will
agree to take part. This sample size will also have 80%
power at the 5% significance level to detect a reduction of
one third in the proportion of people with one or more
falls, with an expected proportion with one or more falls
of 50% at 12 months.
Data monitoring and analysis
Data will be double entered into Access to check data
entry validity and analysis performed using SPSS (version
11) and Stata (version 8). Intention to treat analysis will
be used. Analysis will performed according to the pre-
specified analysis plan.
Univariate and multivariate analyses
For the primary analysis, Poisson regression or if there is
over-dispersion (likely), negative binomial regression will
be used to estimate the incidence rate ratio comparing the
rate of falls between the two randomised groups during
the follow-up period. The number of falls will be the
numerator and length of follow-up the denominator.
Secondary analysis will compare the following outcomes
between treatment arms:
a) The proportion of people with one or more falls over
the follow-up period, using logistic regression
b) Time to first fall using survival analysis
c) the proportion of people with injurious falls using
logistic regression
d) the proportion of people institutionalised at 12
months using logistic regression
e) Impact on disability, quality of life, fear of falls, and use
of health services will be assessed using linear regression
models with transformations if necessary, although some
of these comparisons will be underpowered.
f) Deaths will be compared between the two groups. The
analysis will be survival analysis using Cox proportional
hazards model.
All analyses will adjust for the strata used in the randomi-
sation procedure. If there are other important baseline dif-
ferences, for example in age or number of previous falls,
multivariate analysis will be used to adjust for them.
Subgroup analyses
We will perform subgroup analysis for age (70–85, 85+)
and falls history in the last year (0–1, ≥2). The statistical
significance of differences between subgroups will be
tested using tests for interaction in the regression models.
Economic analyses
Cost-effectiveness analysis taking a societal perspective,
including NHS, patient and social services support will be
carried out using established methods[28]. Incremental
Table 1: Trial documentation
Form title Completed/sent by
Screening questionnaire Potential participant
Invitation pack (PIL, falls advice, consent) Potential participant
No phone letter v1 Project officer
Consent form Potential participant
Confirmatory letter (randomised group, diary 1, DH appointment) Project officer
Exclusion letter to pts Project officer
Diary completion reminder Project officer
Diary 2–11 Participant
Acute hospital event form/case note abstraction Project officer
GP event form/case note abstraction Project officer
Day hospital resource use Multidisciplinary team
Final outcome pack (FES, NEADL, EuroQoL, diary 12) Potential participant
Follow-up only falls enquiry Non-RCT follow up only participantTrials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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cost-effectiveness ratios will be calculated based on the
duration of the trial only.
Resource use data will be collected with respect to inpa-
tient and outpatient staff time (Consultants, GP, nurses,
physiotherapists, and occupational therapists), Overhead
costs, diagnostic tests (radiology and blood services),
dressings, medication, transport costs (NHS and private),
patient out-of-pocket costs and patient/carer time costs.
Resource use data will be collected using a report form
abstracting from patient records as well as the patient dia-
ries at monthly intervals throughout the trial for both the
intervention and control groups. These data will be cross
referenced, where appropriate, with GP records and pre-
scribing systems.
Health and social care resource use data will be valued
using published unit cost data[22,23] Social care items
will include the number and duration of carer visits per
day, and the use of home food delivery services. Time
costs will be valued using published wage rates from the
new earnings survey and patient out-of-pocket costs will
be reported directly by the patient.
The principal outcome measure will be the number of
falls prevented to give the incremental cost per fall pre-
vented and Quality Adjusted Life Years as measured on
the EuroQol EQ-5D to produce the cost per QALY.
No discounting will be necessary as the trial period is 12
months. One way sensitivity analysis of extremes to test
the robustness of the estimated incremental cost-effective-
ness ratios will be undertaken.
Project management and administration
Project management
The project will be managed day to day by the project
manager (SC) working in close partnership with the
project officer (RT) and study secretary (Stephanie Sut-
cliffe). A steering group will meet monthly (SC, RT, TM,
DK) and the overall study group will meet three-monthly
(all investigators).
The project will first start in Nottingham; RT and Dr
Drummond will be responsible for the training and prep-
aration of the day hospital staff as well as the preparation
of the participating practices. The project will then be
rolled out sequentially to Derby, with RT and SC provid-
ing close support.
We will be seeking to ensure that the core intervention is
uniform across the day hospitals, although some local
variation is to be expected. The uniformity of the interven-
tion will be monitored using audit and direct observation
(initially weekly, later monthly and then three monthly –
AD). The day hospitals will be assessed to ensure that:
• the local set up and structure is appropriate
• the appropriate staff are providing the appropriate inter-
ventions
The financial management of the project will be control-
led by SC and TM, with quarterly reviews with the investi-
gators
Procedure for recruiting general practices
The collaborative research network (CRN) is an estab-
lished network of General Practices in Trent who have
indicated their willingness to be involved in studies. Sub-
ject to their approval of this study, we will use this net-
work to recruit willing practices.
The day hospitals in Derby and Nottingham, along with
their respective physicians have been recruited already.
Trial documentation
The documents required to be completed and by whom
are highlighted in table 1.
Record retention
Data will be stored in compliance with data protection
act. All records will be stored for seven years from the date
of the last study publication
Table 2: Project milestones
From To Activity
4/2004 8/04 Planning & preparation. Procurement of honorary contracts
6/2004 Submission to COREC and Research & Development offices
8/04 12/04 Pilot phase (Nottingham). Preparation of other participating centres
12/04 Start of recruitment – Nottingham.
3/05 First interim analysis (Nottingham)
1/06 First centre – one year results
4/07 Final data analysis
4/07 8/07 Writing of report and papers for publication, preparing dissemination through presentation at local, 
national and international meetings, preparation for applications for further peer-reviewed grantsTrials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
Page 8 of 10
(page number not for citation purposes)
Participant flow Figure 1
Participant flow.
N=1250 
Exclusions: GDH attendees 
(RT), terminal illness (GP), 
Excluded or decline 
(some baseline 
data available) 
N = 600 
Eligible 
N= 1000 
Provide information pack 
Telephone call 
Consent posted with baseline data collection 
Baseline data: age, mobility, comorbidity, falls 
(0-1,>1), centre. N = 400 
Control 
N = 200 
Intervention 
N = 200
Follow up data: 
Monthly falls diaries 
1 year FU data – 
QoL, ADLs, service 
utilisation 
20% ineligible 
(Estimate)
40% accept 
Screening 
questionnaire, PIL 
N= 3125
40% at 
risk of falls
FU monthly (brief diary & end 
of study booklet) for ‘low risk’ 
or excluded who have 
returned the questionnaire Trials 2006, 7:5 http://www.trialsjournal.com/content/7/1/5
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Payments
We are unable to offer any payments to participants, how-
ever, transport to and from the day hospital will be pro-
vided, along with meals and refreshments. The general
practices will be each paid £60 in lieu of their time and
effort in disseminating the original screening question-
naire and affording subsequent access to records. The
project officer and manager will be reimbursed for any rel-
evant travel expense. Attendance at the group meetings by
the investigators will also be reimbursed.
Project milestones
See table 2.
Informed consent
Verbal consent will be obtained from all participants
where possible. Participants will be asked to return a
signed consent form indicating that they have received
sufficient information during the telephone conversation.
They will have the option of being visited at home if the
telephone medium hinders fully informed verbal consent.
In the event of communication difficulties, the project
officer will be able to visit the participant and their advo-
cate in their home with a view to obtaining written con-
sent or assent from the advocate. There will be no formal
testing of cognitive function, but if it is felt that the poten-
tial participant will not be able to follow the required
study protocol and/or attendances at the day hospital,
then they will be excluded.
The study website will be made available to participants
and their relatives, giving further information on falls pre-
vention[29].
Confidentiality
All participant questionnaires and case note abstraction
forms will be stored in locked cabinets, identified by a
unique participant identifier. Consent forms and other
documents including the participants name will be stored
separately from questionnaires and other trial documents
in locked cabinets. All computer databases will include
the unique participant identifier and not the name and
address of the participant.
Publications
All investigators will contribute towards drafting the
paper reporting the main trial findings and all investiga-
tors will be named authors on that paper, providing they
fulfill the Vancouver criteria for authorship.
Investigators wishing to analyse and report other findings
from the study can do so on the agreement of the other
investigators, and the study team will agree authorship for
these papers, subject to the Vancouver criteria for author-
ship.
It has been agreed by the study team and project officer
that SC (project manager) will be able to use the study and
the data for the basis of his PhD thesis.
Authors' contributions
• TM and RH developed the original idea, study design
and obtained pump-priming funding. SC contributed to
the study design and obtinaed the main funding. CC, AD,
JG, DK, PK, RM, TS and JY all contributed to study design
and are pump-priming grant holders. RT improved on the
study design and helped with data collection. All authors
read and approved the final manuscript. The authors
declare that they have no competing interests.
Ethics approval
COREC approval has been obtained from the Notting-
ham main REC and the relevant local RECs (reference: 04/
Q2404/93).
Chief investigator: Pr Masud; principal investigators at
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